{
    "clinical_study": {
        "@rank": "1486", 
        "arm_group": {
            "arm_group_label": "Mesenchymal stem cell", 
            "arm_group_type": "Other", 
            "description": "Intravenous transfer of Mesenchymal Stem Cell ( MSCs )"
        }, 
        "brief_summary": {
            "textblock": "Mental retardation is a condition diagnosed before age 18 that includes below-average\n      general intellectual function, and a lack of the skills necessary for daily living. Mental\n      retardation affects about 1 - 3% of the population. There are many causes of mental\n      retardation, but find a specific reason in only 25% of cases.Bone marrow derived stem cells\n      are used in this condition to prove its safety and efficacy ."
        }, 
        "brief_title": "Safety and Efficacy of Mesenchymal Stem Cell in Patients With Mental Retardation", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Mental Retardation", 
        "condition_browse": {
            "mesh_term": "Mental Retardation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age limit: 5 -50\n\n          -  Primary diagnosis of mental retardation (IQ < 70)\n\n          -  willingness to undergo Bone marrow and umbilical cord derived Mesenchymal stem cell\n             transplantation.\n\n          -  To give an informed consent as well as sign the required Informed Consent Form\n             (ICF)/video Consent for the study.\n\n          -  willingness to regularly visit the hospital / clinic for follow up during the follow\n             up period / on prior agreed time points as per the protocol.\n\n        Exclusion Criteria:\n\n          -  Positive test results for HIV and AIDS complex ,HCV (hepatitis C virus ), HbsAg and\n             Syphilis\n\n          -  Advanced age that may produce deteriorating cognitive or motor functioning\n\n          -  Multiple sensory or motor disabilities that will interfere with seeing the stimuli\n             and responding to the computer\n\n          -  Poor general health"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "5 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01908400", 
            "org_study_id": "CSCC/BMMR/2013//01"
        }, 
        "intervention": {
            "arm_group_label": "Mesenchymal stem cell", 
            "description": "Intervention therapy , Total 6 doses ,in 30 days ,in 7days interval Intravenous transfer of Bone marrow derived Mesenchymal Stem Cell ( MSCs )", 
            "intervention_name": "Intravenous transfer of Mesenchymal Stem Cell ( MSCs )", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Mental retardation ,Mesenchymal stem cell,", 
        "lastchanged_date": "October 8, 2013", 
        "location": {
            "contact": {
                "email": "sac2751982@gmail.com", 
                "last_name": "Sachin P Jamadar, D ORTHO", 
                "phone": "+918888788880"
            }, 
            "facility": {
                "address": {
                    "city": "Pune,", 
                    "country": "India", 
                    "state": "Maharashtra", 
                    "zip": "411030"
                }, 
                "name": "Chaitanya Hospital"
            }, 
            "investigator": {
                "last_name": "Anant E Bagul, MS,Ortho", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "1", 
        "official_title": "An Open Labeled Clinical Study to Evaluate the Safety and Efficacy of Bone Marrow Derived Mesenchymal Stem Cell in Patients With Mental Retardation.", 
        "overall_contact": {
            "email": "sac2751982@gmail.com", 
            "last_name": "Sachin P Jamadar, D.Ortho", 
            "phone": "918888788880"
        }, 
        "overall_contact_backup": {
            "email": "drsmitabhoyar@rediff.com", 
            "last_name": "Smita S Bhoyar, B.A.M.S.PGCR", 
            "phone": "9372620569"
        }, 
        "overall_official": {
            "affiliation": "Chaitanya Hospital", 
            "last_name": "ANANT E BAGUL, MS ORTHO", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "CHANGE in IQ as measured by Binet-Kamat Test", 
            "measure": "Binet-Kamat Test", 
            "safety_issue": "No", 
            "time_frame": "1 YEAR"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01908400"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chaitanya Hospital, Pune", 
            "investigator_full_name": "Dr. Sachin Jamadar", 
            "investigator_title": "Co -investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "CHANGE in Social Quotient as measured by Vineland Social Maturity Scale", 
            "measure": "Vineland Social Maturity Scale", 
            "safety_issue": "No", 
            "time_frame": "baseline and 12 months"
        }, 
        "source": "Chaitanya Hospital, Pune", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chaitanya Hospital, Pune", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}